„Proteome of human plasma very low-density lipoprotein and low-density lipoprotein exhibits a link with coagulation and lipid metabolism”. Thromb. Haemost. 111 (3): 518–530. . doi:10.1160/TH13-02-0178. PMID24500811.
Ravnskov U, de Lorgeril M, Diamond DM, Hama R, Hamazaki T, Hammarskjöld B, Hynes N, Kendrick M, Langsjoen PH, Mascitelli L, McCully KS, Okuyama H, Rosch PJ, Schersten T, Sultan S, Sundberg R (). „LDL-C does not cause cardiovascular disease: a comprehensive review of the current literature”. Expert Rev Clin Pharmacol. 11: 959–970. doi:10.1080/17512433.2018.1519391. PMID30198808.Mentenanță CS1: Nume multiple: lista autorilor (link)
„Small LDL and its clinical importance as a new CAD risk factor: a female case study”. Progress in Cardiovascular Nursing. 17 (4): 167–73. . doi:10.1111/j.0889-7204.2002.01453.x. PMID12417832.
Stocker, Roland; Keaney, John F. (). „Role of Oxidative Modifications in Atherosclerosis”. Physiological Reviews. 84 (4): 1381–1478. doi:10.1152/physrev.00047.2003. PMID15383655.
Birukov, K. G. (). „Oxidized lipids: The two faces of vascular inflammation”. Current Atherosclerosis Reports. 8 (3): 223–31. doi:10.1007/s11883-006-0077-x. PMID16640959.
„Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula”. Clinical Biochemistry. 36 (7): 499–504. octombrie 2003. doi:10.1016/S0009-9120(03)00117-6. PMID14563441.
William E. Boden, M.D.; et al. (aprilie 2007). „Optimal Medical Therapy with or without PCI for Stable Coronary Disease”. The New England Journal of Medicine. 356 (15): 1503–1516. doi:10.1056/NEJMoa070829. PMID17387127.
Peter P. Toth; Michael Grabner; Rajeshwari S. Punekar; Ralph A. Quimbo; Mark J. Cziraky; Terry A. Jacobson (august 2014). „Cardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targets”. Atherosclerosis. 235 (2): 585–591. doi:10.1016/j.atherosclerosis.2014.05.914. PMID24956532.
Krauss RM (august 2010). „Lipoprotein subfractions and cardiovascular disease risk”. Current Opinion in Lipidology. 21 (4): 305–11. doi:10.1097/MOL.0b013e32833b7756. PMID20531184.
„Nicotinic acid receptor subtypes and their ligands”. Medicinal Research Reviews. 27 (3): 417–33. mai 2007. doi:10.1002/med.20102. PMID17238156.
„WHO cooperative trial on primary prevention of ischemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up. Report of the Committee of Principal Investigators”. Lancet. 2 (8403): 600–4. septembrie 1984. doi:10.1016/s0140-6736(84)90595-6. PMID6147641.
Song, B.L.; DeBose-Boyd, R.A. (). „Insig-Dependent Ubiquitination and Degradation of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Stimulated by Delta- and Gamma-Tocotrienols”. J. Biol. Chem. 281 (35): 25054–25601. doi:10.1074/jbc.M605575200. PMID16831864.
„Proteome of human plasma very low-density lipoprotein and low-density lipoprotein exhibits a link with coagulation and lipid metabolism”. Thromb. Haemost. 111 (3): 518–530. . doi:10.1160/TH13-02-0178. PMID24500811.
Ravnskov U, de Lorgeril M, Diamond DM, Hama R, Hamazaki T, Hammarskjöld B, Hynes N, Kendrick M, Langsjoen PH, Mascitelli L, McCully KS, Okuyama H, Rosch PJ, Schersten T, Sultan S, Sundberg R (). „LDL-C does not cause cardiovascular disease: a comprehensive review of the current literature”. Expert Rev Clin Pharmacol. 11: 959–970. doi:10.1080/17512433.2018.1519391. PMID30198808.Mentenanță CS1: Nume multiple: lista autorilor (link)
„Small LDL and its clinical importance as a new CAD risk factor: a female case study”. Progress in Cardiovascular Nursing. 17 (4): 167–73. . doi:10.1111/j.0889-7204.2002.01453.x. PMID12417832.
Staprans, I.; Rapp, J. H.; Pan, X. M.; Feingold, K. R. (). „Oxidized lipids in the diet are incorporated by the liver into very low density lipoprotein in rats”. Journal of Lipid Research. 37 (2): 420–30. PMID9026539.
Stocker, Roland; Keaney, John F. (). „Role of Oxidative Modifications in Atherosclerosis”. Physiological Reviews. 84 (4): 1381–1478. doi:10.1152/physrev.00047.2003. PMID15383655.
Birukov, K. G. (). „Oxidized lipids: The two faces of vascular inflammation”. Current Atherosclerosis Reports. 8 (3): 223–31. doi:10.1007/s11883-006-0077-x. PMID16640959.
„Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula”. Clinical Biochemistry. 36 (7): 499–504. octombrie 2003. doi:10.1016/S0009-9120(03)00117-6. PMID14563441.
William E. Boden, M.D.; et al. (aprilie 2007). „Optimal Medical Therapy with or without PCI for Stable Coronary Disease”. The New England Journal of Medicine. 356 (15): 1503–1516. doi:10.1056/NEJMoa070829. PMID17387127.
Peter P. Toth; Michael Grabner; Rajeshwari S. Punekar; Ralph A. Quimbo; Mark J. Cziraky; Terry A. Jacobson (august 2014). „Cardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targets”. Atherosclerosis. 235 (2): 585–591. doi:10.1016/j.atherosclerosis.2014.05.914. PMID24956532.
Krauss RM (august 2010). „Lipoprotein subfractions and cardiovascular disease risk”. Current Opinion in Lipidology. 21 (4): 305–11. doi:10.1097/MOL.0b013e32833b7756. PMID20531184.
„Nicotinic acid receptor subtypes and their ligands”. Medicinal Research Reviews. 27 (3): 417–33. mai 2007. doi:10.1002/med.20102. PMID17238156.
„WHO cooperative trial on primary prevention of ischemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up. Report of the Committee of Principal Investigators”. Lancet. 2 (8403): 600–4. septembrie 1984. doi:10.1016/s0140-6736(84)90595-6. PMID6147641.
Song, B.L.; DeBose-Boyd, R.A. (). „Insig-Dependent Ubiquitination and Degradation of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Stimulated by Delta- and Gamma-Tocotrienols”. J. Biol. Chem. 281 (35): 25054–25601. doi:10.1074/jbc.M605575200. PMID16831864.
John D. Brunzell, MD, FACP, Michael Davidson, MD, FACC, Curt D. Furberg, MD, PhD, Ronald B. Goldberg, MD, Barbara V. Howard, PhD, James H. Stein, MD, FACC, FACP and Joseph L. Witztum, MD Lipoprotein Management in Patients With Cardiometabolic Risk, J Am Coll Cardiol, 2008; 51:1512-1524. „copie arhivă”. Arhivat din original la . Accesat în .
John D. Brunzell, MD, FACP, Michael Davidson, MD, FACC, Curt D. Furberg, MD, PhD, Ronald B. Goldberg, MD, Barbara V. Howard, PhD, James H. Stein, MD, FACC, FACP and Joseph L. Witztum, MD Lipoprotein Management in Patients With Cardiometabolic Risk, J Am Coll Cardiol, 2008; 51:1512-1524. „copie arhivă”. Arhivat din original la . Accesat în .